Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Long Term Use of Monthly Temozolomide in Patients with Oligodendroglioma: Feasibility and Tolerability of Two Years of Therapy
Neuro-oncology
(-)
002
Authors/Disclosures
Tsz Ching Li, MD (Department of Medicine, Queen Elizabeth Hospital) No disclosure on file
Nikolaos Petsas No disclosure on file
Peter Hedera, MD (Vanderbilt University) Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
No disclosure on file
No disclosure on file
No disclosure on file
Floriana De Angelis, MD No disclosure on file
No disclosure on file
No disclosure on file
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Patrizia Pantano Patrizia Pantano has nothing to disclose.
No disclosure on file